iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025.

Area of Science:

• Cardiology
• Global Health
• Evidence-Based Medicine

Background:

• Current heart failure (HF) guidelines face limitations in global applicability due to healthcare inconsistencies, resource constraints, and diverse practices.
• There is a critical need for universal recommendations addressing worldwide challenges in HF patient care and clinical practice.

Purpose of the Study:

• To present the iCARDIO Alliance Global Implementation Guidelines for heart failure (HF) management.
• To integrate novel therapies and current evidence into a unified strategy applicable globally, considering resource limitations.

Main Methods:

• Development of evidence-based recommendations through group consensus, considering existing guidelines and recent evidence.
• Inclusion of context-specific recommendations tailored to individual patient needs and resource availability ('economic adjustments').
• Comprehensive review of pharmacological, non-pharmacological, invasive, and interventional management strategies for HF.

Main Results:

• The guidelines offer a unified strategy for HF management, applicable across diverse global healthcare settings.
• Specific recommendations address resource limitations, providing guidance for 'somewhat limited' and 'severely limited' resource scenarios.
• Emphasis on optimizing patient care by incorporating novel therapies and the latest evidence for acute/chronic HF, HF with reduced/preserved ejection fraction, and cardiomyopathies.

Conclusions:

• These global HF guidelines provide a comprehensive and concise update, aiming to standardize care and improve patient outcomes worldwide.
• The guidelines empower clinicians to optimize HF management by evaluating risks, benefits, and value of therapies, even in resource-constrained environments.
• Implementation of these guidelines is expected to reduce hospitalizations and the overall burden of heart failure as a global health challenge.